Current drug and molecular therapies for the treatment of atrophic age-related macular degeneration: phase I to phase III clinical development.
about
Current drug and molecular therapies for the treatment of atrophic age-related macular degeneration: phase I to phase III clinical development.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Current drug and molecular the ...... hase III clinical development.
@en
Current drug and molecular the ...... hase III clinical development.
@nl
type
label
Current drug and molecular the ...... hase III clinical development.
@en
Current drug and molecular the ...... hase III clinical development.
@nl
prefLabel
Current drug and molecular the ...... hase III clinical development.
@en
Current drug and molecular the ...... hase III clinical development.
@nl
P2093
P2860
P1476
Current drug and molecular the ...... hase III clinical development.
@en
P2093
Huiling Li
Monica M Jablonski
Sumana R Chintalapudi
P2860
P304
P356
10.1080/13543784.2017.1369042
P407
P577
2017-08-17T00:00:00Z